COVID patients receiving antibiotics worsened global antimicrobial resistance

  28 May 2022

Over the course of the pandemic, millions of people around the world have been admitted to hospitals with COVID-19. And, because coronavirus symptoms can be hard to distinguish from pneumonia and other bacterial infections, many of these patients are prescribed broad-spectrum antibiotics.

In a recent published study, researchers with Alberta’s  Antimicrobial Resistance (AMR) – One Health Consortium have found this common hospital practice may be acting “as a catalyst” to increase global antimicrobial resistance (AMR).

Further reading: University of Calgary
Author(s): University of Calgary
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!